...Inverness' Biosite Inc. subsidiary will develop and select antibodies that bind to Compugen's CGEN-144 , a variant... ...variant of troponin 1. Troponin 1 is a biomarker used to diagnose myocardial infarction (MI). Biosite...
...connection with the September MEDX deal, Oxford Genome also expanded on a 2006 deal with Biosite Inc.... ...develop companion diagnostics for Oxford Genome's antibody therapeutics using jointly selected cancer targets from OGAP. Biosite...
...Anatomy of a bidding war From a position of wanting to go it alone, Biosite's board... ...reported in the SEC filings, in which the identities of several players are masked. Source: Biosite's...
...Inverness' Biosite Inc. subsidiary will develop and select antibodies that bind to Compugen's CGEN-144 , a variant... ...variant of troponin 1. Troponin 1 is a biomarker used to diagnose myocardial infarction (MI). Biosite...
...connection with the September MEDX deal, Oxford Genome also expanded on a 2006 deal with Biosite Inc.... ...develop companion diagnostics for Oxford Genome's antibody therapeutics using jointly selected cancer targets from OGAP. Biosite...
...Anatomy of a bidding war From a position of wanting to go it alone, Biosite's board... ...reported in the SEC filings, in which the identities of several players are masked. Source: Biosite's...